Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,825
Active & Responsive
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for
Overweight, Obesity
Location: Greensboro NC, Danville VA, Monroe NC, New Bern NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07589608
Phase 2, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
for
Obesity, Overweight and/or Obesity, Overweight
Location: Greensboro NC, Wilmington NC, Norfolk VA, Baltimore MD,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07595549
Phase 3, Recruiting
Active & ResponsiveNew
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Get alerts for new trials in your area by subscribing now
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Greensboro NC, Reidsville NC, Chapel Hill NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase 2, Recruiting
Active & Responsive
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
for
Ulcerative Colitis (UC), Crohn's Disease (CD),
Location: Winston-Salem NC, Chapel Hill NC, Charlotte NC,
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18+
Code: NCT07237516
Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease